Press releasePRNewswire
DaVita
DVA · NYSE
$175.35−$11.65 (−6.23%)TodayMarket closed ·
Prev close $187.00
Latest news
- NewsPiero Cingari
Health Care Stocks Hit Record Highs, GM Drops Nearly 8%: Stock Market Today
- Press releasePRNewswire
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
- Press releasePRNewswire
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
- Press releasePRNewswire
DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early
- NewsRishabh Mishra
Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’
- News
10 Health Care Stocks Whale Activity In Today’s Session
- NewsChris Katje
Warren Buffett, Donald Trump Bet on Same 17 Stocks — Some Might Surprise You
- NewsVandana Singh
DaVita Reaches Preliminary Settlement Class Agreement Following Ransomware Attack
- NewsRadhika Anilkumar Nadig
Berkshire Hathaway Cut Capital One Stake by 58% in Q2 — Billionaire Dan Loeb Is Doing the Exact Opposite
- Press releasePRNewswire
Alebund Pharmaceuticals Announces 2026 Interim Results
- Press releasePRNewswire
DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease
- NewsPiero Cingari
The Economy Lost Jobs, Wall Street Threw a Party: What Moved Markets This Week
- NewsPiero Cingari
Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today
- NewsAvi Kapoor
SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- News
DaVita Q2 Adj. EPS $4.02 Beats $3.88 Estimate, Sales $3.554B Beat $3.496B Estimate
- Press releasePRNewswire
DaVita Inc. 2nd Quarter 2026 Results
- Press releasePRNewswire
DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call
- News
8 Health Care Stocks Whale Activity In Today’s Session
- Press releasePRNewswire
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals
- NewsPiero Cingari
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
- Press releasePRNewswire
DaVita Inc. 1st Quarter 2026 Results
- Press releasePRNewswire
Honeywell Announces Board of Directors for Honeywell Aerospace
- Press releasePRNewswire
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
- Press releasePRNewswire
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
- Press releasePRNewswire
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
- Press releaseGlobe Newswire
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
- Press releasePRNewswire
DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference
- NewsVandana Singh
DaVita Stock Rallies On Profit Beat, Confident 2026 View
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Silver Surges Over 15%; Pfizer Earnings Top Views
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releasePRNewswire
DaVita Inc. 4th Quarter 2025 Results
- Press releaseBusiness Wire
Elara Caring Secures New Strategic Investment from Ares and DaVita
- Press releaseBusiness Wire
Tolion Health AI Appoints Global Health & AI Leader Gregory J. Moore, MD, PhD, to Board of Directors
- Press releasePRNewswire
DaVita Inc. 3rd Quarter 2025 Results
- Press releasePRNewswire
DaVita Inc. 2nd Quarter 2025 Results
- NewsSnigdha Gairola
Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.